Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Among authors: fedullo p. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Among authors: fedullo p. Lancet Respir Med. 2017 Oct;5(10):785-794. doi: 10.1016/S2213-2600(17)30305-3. Epub 2017 Sep 11. Lancet Respir Med. 2017. PMID: 28919201 Retracted and republished. Retracted. Clinical Trial.
Chronic thromboembolic pulmonary hypertension.
Auger WR, Kerr KM, Kim NH, Ben-Yehuda O, Knowlton KU, Fedullo PF. Auger WR, et al. Cardiol Clin. 2004 Aug;22(3):453-66, vii. doi: 10.1016/j.ccl.2004.04.006. Cardiol Clin. 2004. PMID: 15302364 Review.
Chronic thromboembolic pulmonary hypertension.
Fedullo PF, Auger WR, Kerr KM, Kim NH. Fedullo PF, et al. Semin Respir Crit Care Med. 2003 Jun;24(3):273-86. doi: 10.1055/s-2003-41088. Semin Respir Crit Care Med. 2003. PMID: 16088548
Chronic thromboembolic pulmonary hypertension.
Fedullo P, Kerr KM, Kim NH, Auger WR. Fedullo P, et al. Am J Respir Crit Care Med. 2011 Jun 15;183(12):1605-13. doi: 10.1164/rccm.201011-1854CI. Epub 2011 Feb 17. Am J Respir Crit Care Med. 2011. PMID: 21330453 Review.
Chronic Thromboembolic Pulmonary Hypertension: JACC Focus Seminar.
Papamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF. Papamatheakis DG, et al. Among authors: fedullo pf. J Am Coll Cardiol. 2020 Nov 3;76(18):2155-2169. doi: 10.1016/j.jacc.2020.08.074. J Am Coll Cardiol. 2020. PMID: 33121723 Free article. Review.
Chronic thromboembolic pulmonary hypertension in pediatric patients.
Madani MM, Wittine LM, Auger WR, Fedullo PF, Kerr KM, Kim NH, Test VJ, Kriett JM, Jamieson SW. Madani MM, et al. J Thorac Cardiovasc Surg. 2011 Mar;141(3):624-30. doi: 10.1016/j.jtcvs.2010.07.010. Epub 2010 Aug 30. J Thorac Cardiovasc Surg. 2011. PMID: 20800245 Free article.
Chronic thromboembolic pulmonary hypertension.
Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Auger WR, et al. Clin Chest Med. 2007 Mar;28(1):255-69, x. doi: 10.1016/j.ccm.2006.11.009. Clin Chest Med. 2007. PMID: 17338940 Review.
98 results